Chinese Chronic Renal Insufficiency Study: Based on Smartphone Platform

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3360 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-10

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multi-center prospective cohort study. The purpose of this study is to investigate the relationship between bone metabolic markers and other non-traditional risk factors with kidney function progression, cardiovascular and cerebrovascular diseases, and bone loss in patients with CKD G3-5ND. In the meantime, this study is to explore a new mode of management and complication monitoring through mobile communication in chronic kidney disease patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases

NCT05188885

Chronic Kidney Disease

RECRUITING

Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease

NCT03246191

Chronic Kidney Disease

UNKNOWN

Chinese Cohort Study of Chronic Kidney Disease

NCT03041987

Renal Insufficiency, Chronic

ACTIVE_NOT_RECRUITING

Chinese Observational Prospective Study of Aging Population With Chronic Kidney Disease(C-OPTION)

NCT03246204

Chronic Kidney Disease

UNKNOWN

A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients

NCT04940819

Chronic Renal Disease

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Abnormal mineral bone metabolism of chronic kidney disease (CKD-MBD) is the most common complication of CKD. It involves kidney, bone metabolism, parathyroid gland, cardiovascular and cerebrovascular organs. It is an independent risk factor for progression of CKD to end-stage renal disease (ESRD), vascular and cardiac valve calcification, and cardiovascular and cerebrovascular events. However, less data concerning the relationship between bone metabolic index, such as high blood phosphorus and cardiovascular diseases, bone mass reduction and fracture is available in Chinese adult patients. This study is a multi-center prospective cohort study to explore the relationship between bone metabolic markers and other non-traditional risk factors with renal function progression, cardiovascular and cerebrovascular diseases, and bone loss in patients with CKD G3-5ND. Based on the sample size estimation, 3360 subjects should be enrolled in this study. The primary outcome is progression to ESRD (start dialysis or kidney transplantation) or doubling of serum creatinine, as well as cardiovascular events and all-cause mortality.

At present, the follow-up and the management of complications of CKD patients are not enough. The popularity of mobile communication in China provide the possibility to strengthen the follow-up and complications management in CKD patients and save human resources. This study is to explore a new mode of collecting datas through mobile communication in chronic kidney disease patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at least two measurements of serum Cr (with a minimum interval of 3 months), , 10≤eGFR≤60ml/min/1.73m\^2

Exclusion Criteria

* Unable or unwilling to provide informed consent
* Patients attending oncology, psychiatry, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), viral hepatitis (HBV or HCV) services
* Acute mycardial infarction within the last six months
* NYHA Class III or IV heart failure at baseline
* Ongoing chemotherapy or immunosuppressive therapy (in the preceding 6 months to treat renal or immune disease)
* Current renal replacement therapy
* Current pregnancy or breastfeeding women
* Any organ transplantation
* Currently participation in an interventional clinical trial

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No